Cysteamine induces duodenal ulcer in the mouse.
A new model of duodenal ulcer disease has been developed in the mouse. The ulcers were produced after either oral or subcutaneous administration of cysteamine which has been shown to cause duodenal ulcer in the rat. Cysteamine induced duodenal ulcers in a time- and dose-dependent manner after oral administration. The new mouse model shares many similarities with both the rat model and human ulcer disease. Cysteamine caused a significant increase in gastric acidity and pepsin activity. The mouse can be protected against the cysteamine-induced duodenal ulcer by either the dopamine agonist lergotrile or histamine H2 receptor antagonist cimetidine. This new model of duodenal ulcer disease in the mouse may represent a simple and inexpensive way to screen for new antiulcerogenic drugs.
Cahill
M C
MC
Gallagher
G T
GT
Szabo
S
S
D000284:Administration, Oral; D000818:Animals; D003543:Cysteamine / Q000008:administration & dosage / Q000494:pharmacology*; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D004381:Duodenal Ulcer / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism; D007279:Injections, Subcutaneous; D051379:Mice
D003543:Cysteamine